Blake Warbington

Assistant Scientist at Cerus

Blake Warbington's Professional Contact Details

Email (Verified)

****@cerus.com

Get Email Address

(925) 288-6000

Location

San Francisco, California, US

Company

Cerus

Person Seniority

entry

Blake Warbington's Current Company Details

Cerus

Concord, California, US • 166 Employees

biotechnology

Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT system is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action enables INTERCEPT treatment to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, and is designed to inactivate emerging pathogens such as influenza, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is in clinical development.

Public Symbol

CERS

Founded Year

2003

Organization Website

cerus.com

Organization Languages

English

Organization Revenue

37200

Current Technologies

google analytics